In gallbladder cancer, m6A modification of TRPM2-AS by METTL3/14 is recognized by IGF2BP2 and promotes tumor angiogenesis through activation of the NOTCH1 signaling pathway (He et al., 2024[76]). This evidence concerns the gene IGF2BP2 and neoplasm.